Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States.

Autor: Molnar D; GSK, Wavre, Belgium. daniel.h.molnar@gsk.com., La EM; GSK, Philadelphia, PA, USA., Verelst F; GSK, Wavre, Belgium., Poston S; GSK, Philadelphia, PA, USA., Graham J; RTI Health Solutions, Research Triangle Park, NC, USA., Van Bellinghen LA; CHESS in Health, Bonheiden, Belgium., Curran D; GSK, Wavre, Belgium.

Publikováno v: Infectious diseases and therapy [Infect Dis Ther] 2024 Apr; Vol. 13 (4), pp. 827-844. Date of Electronic Publication: 2024 Mar 20.

The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis.

Autor: Kurai D; Department of General Medicine, Kyorin University School of Medicine, Tokyo, Japan., Mizukami A; GSK, Tokyo, Japan., Preckler V; GSK, Wavre, Belgium., Verelst F; GSK, Wavre, Belgium., Molnar D; GSK, Wavre, Belgium., Matsuki T; GSK, Tokyo, Japan., Ho Y; GSK, Singapore, Singapore., Igarashi A; Department of Public Health, Yokohama City University, Kanagawa, Japan.; Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.

Publikováno v: Expert review of vaccines [Expert Rev Vaccines] 2024 Jan-Dec; Vol. 23 (1), pp. 303-311. Date of Electronic Publication: 2024 Mar 01.

EE331 Leveraging Time-Use Data to Estimate Market and Non-Market Productivity Losses Due to Respiratory Syncytial Virus (RSV) Disease Among Adults Aged ≥60 Years in the United States (US)

Autor: Verelst, F., La, E.M., Graham, J., Molnar, D.

Publikováno v: In Value in Health June 2023 26(6) Supplement:S120-S120

Different forms of superspreading lead to different outcomes: Heterogeneity in infectiousness and contact behavior relevant for the case of SARS-CoV-2.

Autor: Kuylen EJ; Centre for Health Economic Research and Modeling Infectious Diseases, University of Antwerp, Antwerp, Belgium.; Data Science Institute, I-BioStat, Hasselt University, Hasselt, Belgium., Torneri A; Centre for Health Economic Research and Modeling Infectious Diseases, University of Antwerp, Antwerp, Belgium., Willem L; Centre for Health Economic Research and Modeling Infectious Diseases, University of Antwerp, Antwerp, Belgium., Libin PJK; Data Science Institute, I-BioStat, Hasselt University, Hasselt, Belgium.; Artificial Intelligence Lab, Vrije Universiteit Brussel, Brussels, Belgium.; Rega Institute for Medical Research, Clinical and Epidemiological Virology, University of Leuven, Leuven, Belgium., Abrams S; Data Science Institute, I-BioStat, Hasselt University, Hasselt, Belgium.; Global Health Institute, University of Antwerp, Antwerp, Belgium., Coletti P; Data Science Institute, I-BioStat, Hasselt University, Hasselt, Belgium., Franco N; Data Science Institute, I-BioStat, Hasselt University, Hasselt, Belgium.; Namur Institute for Complex Systems, Department of Mathematics, University of Namur, Namur, Belgium., Verelst F; Centre for Health Economic Research and Modeling Infectious Diseases, University of Antwerp, Antwerp, Belgium., Beutels P; Centre for Health Economic Research and Modeling Infectious Diseases, University of Antwerp, Antwerp, Belgium.; School of Public Health and Community Medicine, The University of New South Wales, Sydney, NSW, Australia., Liesenborgs J; Expertise Centre for Digital Media, Hasselt University - transnational University Limburg, Hasselt, Belgium., Hens N; Centre for Health Economic Research and Modeling Infectious Diseases, University of Antwerp, Antwerp, Belgium.; Data Science Institute, I-BioStat, Hasselt University, Hasselt, Belgium.

Publikováno v: PLoS computational biology [PLoS Comput Biol] 2022 Aug 22; Vol. 18 (8), pp. e1009980. Date of Electronic Publication: 2022 Aug 22 (Print Publication: 2022).

Individual factors influencing COVID-19 vaccine acceptance in between and during pandemic waves (July-December 2020).

Autor: Valckx S; Centre for the Evaluation of Vaccination, VAXINFECTIO, Faculty of Medicine and Health Sciences, University of Antwerp, 2000 Antwerpen, Belgium. Electronic address: sara.valckx@uantwerpen.be., Crèvecoeur J; Leuven Biostatistics and statistical Bioinformatics Centre (L-BioStat), Faculty of Medicine, KU Leuven, Kapucijnenvoer 35, building D, box 7001, 3000 Leuven, Belgium; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BioStat), Data Science Institute, Hasselt University, Martelarenlaan 42, 3500 Hasselt, Belgium. Electronic address: jonas.crevecoeur@kuleuven.be., Verelst F; Centre for Health Economics Research and Modelling Infectious Diseases, VAXINFECTIO, Faculty of Medicine and Health Sciences, University of Antwerp, 2000 Antwerpen, Belgium. Electronic address: frederik.Verelst@uantwerpen.be., Vranckx M; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BioStat), Data Science Institute, Hasselt University, Martelarenlaan 42, 3500 Hasselt, Belgium. Electronic address: maren.vranckx@uhasselt.be., Hendrickx G; Centre for the Evaluation of Vaccination, VAXINFECTIO, Faculty of Medicine and Health Sciences, University of Antwerp, 2000 Antwerpen, Belgium. Electronic address: greet.hendrickx@uantwerpen.be., Hens N; Centre for Health Economics Research and Modelling Infectious Diseases, VAXINFECTIO, Faculty of Medicine and Health Sciences, University of Antwerp, 2000 Antwerpen, Belgium; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BioStat), Data Science Institute, Hasselt University, Martelarenlaan 42, 3500 Hasselt, Belgium. Electronic address: niel.hens@uantwerpen.be., Van Damme P; Centre for the Evaluation of Vaccination, VAXINFECTIO, Faculty of Medicine and Health Sciences, University of Antwerp, 2000 Antwerpen, Belgium. Electronic address: pierre.vandamme@uantwerpen.be., Pepermans K; Faculty of Social Sciences, University of Antwerp, Sint-Jacobstraat 2, 2000 Antwerpen, Belgium. Electronic address: koen.pepermans@uantwerpen.be., Beutels P; Centre for Health Economics Research and Modelling Infectious Diseases, VAXINFECTIO, Faculty of Medicine and Health Sciences, University of Antwerp, 2000 Antwerpen, Belgium. Electronic address: philippe.beutels@uantwerpen.be., Neyens T; Leuven Biostatistics and statistical Bioinformatics Centre (L-BioStat), Faculty of Medicine, KU Leuven, Kapucijnenvoer 35, building D, box 7001, 3000 Leuven, Belgium; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BioStat), Data Science Institute, Hasselt University, Martelarenlaan 42, 3500 Hasselt, Belgium. Electronic address: thomas.neyens@uhasselt.be.

Publikováno v: Vaccine [Vaccine] 2022 Jan 03; Vol. 40 (1), pp. 151-161. Date of Electronic Publication: 2021 Dec 01.